N-Acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury

Annals of Neurology

Volumn 61, Issue 3, 2007, Pages 263-271

  Wang, Xiaoyang ^a,b   Svedin, Pernilla ^a   Nie, Chunxia ^a,b   Lapatto, Risto ^c   Zhu, Changlian ^a,b   Gustavsson, Malin ^a   Sandberg, Mats ^a   Karlsson, Jan Olof ^a   Romero, Roberto ^d   Hagberg, Henrik ^a,e   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ZHENGZHOU UNIVERSITY   (China)

^c UNIVERSITY OF HELSINKI   (Finland)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; ANTIOXIDANT; CALPAIN; CASPASE 3; FREE RADICAL; GLUTATHIONE; INTERLEUKIN 1BETA CONVERTING ENZYME; ISOPROSTANE; LIPOPOLYSACCHARIDE; MELATONIN; SCAVENGER; THIOREDOXIN; THIOREDOXIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME INHIBITION; INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SENSITIZATION; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CALPAIN; CASPASES; CYSTINE; ENZYME ACTIVATION; GLUTATHIONE; HYPOXIA-ISCHEMIA, BRAIN; ISOPROSTANES; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; RATS; RATS, WISTAR; THIOREDOXIN; TYROSINE;

EID: 34147182756     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21066     Document Type: Article

References (62)

1. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1574-1584.
2. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365:663-670.
3. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002;7:259-274.
4. Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998;317:1554-1558.
5. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278:207-211.
6. Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight. Am J Obstet Gynecol 1998;179:507-513.
7. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic: ischaemic injury. Eur J Neurosci 2001;13:1101-1106.
8. Eklind S, Mallard C, Arvidsson P, Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 2005;58: 112-116.
9. Ferriero DM. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 2001;23:198-202.
10. Horowitz RS, Dart RC, Jarvie DR, et al. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol 1997;35:447-451.
11. Riggs BS, Bronstein AC, Kulig K, et al. Acute acetaminophen overdose during pregnancy. Obstet Gynecol 1989;74:247-253.
12. Beloosesky R, Gayle DA, Amidi F, et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol 2006;194:268-273.
13. Santangelo F. Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr Med Chem 2003;10:2599-2610.
14. Hagberg H, Bona E, Gilland E, Puka-Sundvall M. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and short-comings. Acta Paediatr Suppl 1997;422:85-88.
15. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-141.
16. Wang X, Zhu C, Qiu L, et al. Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J Neurochem 2003;86: 351-362.
17. Wang X, Zhu C, Gerwien JG, et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 2004;91:900-910.
18. Auer M, Pfister LA, Leppert D, et al. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J Infect Dis 2000;182:347-350.
19. Cuzzocrea S, Mazzon E, Costantino G, et al. Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol 2000;130:1219-1226.
20. Husson I, Mesples B, Bac P, et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002;51:82-92.
21. Sekhon B, Sekhon C, Khan M, et al. N-acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 2003;971:1-8.
22. Liu Y, Silverstein FS, Skoff R, Barks JD. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002;51: 25-33.
23. Svedin P, Kjellmer I, Welin A, et al. Maturational effects of lipopolysaccharide on white-matter injury in fetal sheep. J Child Neurol 2005;20:960-964.
24. Hedtjarn M, Mallard C, Arvidsson P, Hagberg H. White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 2005;373:16-20.
25. Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003;84:1173-1183.
26. Ferrari G, Van CY, Greene LA. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 1995;15:2857-2866.
27. Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-564.
28. Xu DX, Chen YH, Wang H, et al. Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicol Sci 2005;88: 525-533.
29. Buhimschi IA, Buhimschi CS, Weiner CP. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003;188: 203-208.
30. Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999;9:69-92.
31. Leviton A, Paneth N. White matter damage in preterm newborns: an epidemiologic perspective. Early Hum Dev 1990; 24:1-22.
32. Back SA, Gan X, Li Y, et al. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-6253.
33. Fragoso G, Martinez-Bermudez AK, Liu HN, et al. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. J Neurochem 2004;90:392-404.
34. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993;13:1441-1453.
35. Mayer M, Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci U S A 1994; 91:7496-7500.
36. Paintlia MK, Paintlia AS, Barbosa E, et al. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 2004;78:347-361.
37. Hedtjarn M, Leverin AL, Eriksson K, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22:5910-5919.
38. Liu XH, Kwon D, Schielke GP, et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999;19:1099-1108.
39. Nathan C. Immunology: oxygen and the inflammatory cell. Nature 2003;422:673-676.
40. Beckman JS, Koppenol WH. Nitric oxide, Superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271:C1424-C1437.
41. Coeroli L, Renolleau S, Arnaud S, et al. Nitric oxide production and perivascular tyrosine nitration following focal ischemia in neonatal rat. J Neurochem 1998;70:2516-2525.
42. Zhu C, Wang X, Qiu L, et al. Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia. J Neurochem 2004;90: 462-471.
43. Akundi RS, Candelario-Jalil E, Hess S, et al. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 2005;51: 199-208.
44. Zujovic V, Schussler N, Jourdain D, et al. In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J Neuroimmunol 2001;115: 135-143.
45. Basu S, Mutschler DK, Larsson AO, et al. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001;50:34l-348.
46. Inder T, Mocatta T, Darlow B, et al. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 2002;52:213-218.
47. Ahola T, Fellman V, Kjellmer I, et al. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004;56: 88-93.
48. Warner DS, Sheng H, Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004;207:3221-3231.
49. Martinez G, Carnazza ML, Campisi A, et al. Effects of glutathione depletors on post-ischemic reperfusion in rat brain. Neurochem Res 1998;23:961-968.
50. Bridgeman MM, Marsden M, MacNee W, et al. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysreine. Thorax 1991; 46:39-42.
51. Burgunder JM, Varriale A, Lauterburg BH. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 1989;36: 127-131.
52. Fullerton HJ, Ditelberg JS, Chen SF, et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 1998;44: 357-364.
53. Rybnikova E, Damdimopoulos AE, Gustafsson JA, et al. Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur J Neurosci 2000;12:1669-1678.
54. Stroev SA, Gluschenko TS, Tjulkova EI, et al. Preconditioning enhances the expression of mitochondrial antioxidant thioredoxin-2 in the forebrain of rats exposed to severe hypobaric hypoxia. J Neurosci Res 2004;78:563-569.
55. Hattori I, Takagi Y, Nozaki K, et al. Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep 2002;7:256-259.
56. Sano H, Sata T, Nanri H, et al. Thioredoxin is associated with endotoxin tolerance in mice. Crit Care Med 2002;30:190-194,
57. Bordet R, Deplanque D, Maboudou P, et al. Increase in endogenous brain Superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab 2000;20:1190-1196.
58. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998;101:1992-1999.
59. Blomgren K, Zhu C, Wang X, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 2001;276: 10191-10198.
60. Haq E, Giri S, Singh I, Singh AK. Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem 2003;86:1428-1440.
61. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-519.
62. Flanagan RJ, Meredith TJ. Use of N-acetylcysteine in clinical toxicology. Am J Med 1991;91:1315-1395.